Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-13

Clinical Trial Update: Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study [NA]

View source ↗

Summary

A completed randomized, placebo-controlled study examining how soy supplementation affects cellular markers in normal and cancerous breast tissue.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soy supplementation (soy isoflavones)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | NA | Status: COMPLETED